The sales of Telminuvo, Exone, Naxozol and Duvie show increasing trend
According to the prescription result per month of new drugs which are released within one year, Telminuvo, Exone, Naxozol and Duvie seem to be seated on the market smoothly.
Telminuvo is a hypertensive treatment which has the same component with a leading marketing item, Twinstar. It was release...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
